Delivery Order SPE2DB22D2206-SPE2DB24FKB93

Award Date 8/30/24
Potential Completion Date 9/3/24
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the provision of Fluticasone Prop HFA 110 MCG 12GM. The award, valued at $3,131.16, is a firm fixed price contract with an ultimate completion date of October 28, 2024. The contract is not designated as a set-aside. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, has significant experience supplying medical products to federal government agencies,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FLUTICASONE PROP HFA 110 MCG 12GM, a prescription medication. The firm-fixed-price delivery order has a ceiling value of $5,892.99 and an ultimate completion date of August 23, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $1,514.71, is for the delivery of 4,564,558,867 units of the pharmaceutical product Fluticasone Prop HFA 110 MCG 12GM. The contract has a completion date of May 10, 2024 and is a firm-fixed price type. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Medical Supply Chain unit of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluticasone Prop HFA 110 MCG 12GM medication. The contract has a firm fixed price of $3,142.24 and a period of performance ending on May 22, 2025. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a $3,059 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of 4,566,073,750 units of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. The contract has a firm fixed price and a period of performance through October 11, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple indefinite delivery contracts (IDCs) by DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,187.36 firm fixed-price delivery order is for the supply of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product. The contract has an ultimate completion date of March 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of FLUTICASONE PROP HFA 110 MCG 12GM. The $3,803.60 firm fixed price contract has a completion date of May 22, 2025. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range of pharmaceutical and medical supplies to support military healthcare...
This is a delivery order award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award, valued at $3,730.00, is for the supply of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. The contract has a period of performance through January 13, 2025 and utilizes a firm fixed-price pricing structure. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,218.22, is for the supply of Fluticasone Prop HFA 110 MCG 12GM, a prescription medication. The contract is a firm fixed-price delivery order with an ultimate completion date of December 4, 2024. AmerisourceBergen is a for-profit organization registered in the System for Award Management...
This contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, provides delivery of Fluticasone Prop HFA 110 MCG 12GM to support federal government medical requirements. The $1,785.36 firm fixed price contract is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 17, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FKB93
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. The contract has a firm fixed price of $2,432.11 and a completion date of September 3, 2024. The award is not associated with a set-aside program. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with the DLA Troop Support Medical for delivering a range of medical commodities to support military treatment programs and facilities worldwide. This delivery order is part of AmerisourceBergen's ongoing role in supplying critical pharmaceutical products and medical supplies to the U.S. government, particularly the Department of Defense and its associated healthcare programs.

Generated 11/29/24, 9:10 AM